Skip to main content
Skip to main content
DNMR logo

Danimer Scientific, Inc. (DNMR)

$0.35 +$0.00 (+0.00%) |CouncilHOLD · 44 · C
Bottom line: HOLD — our Council read (44/100) and AI Score (44/100) broadly agree.
MCap: $1.06M| Vol: 128.4K| 52-wk range: $0.33 – $1.85
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Danimer Scientific, Inc. (DNMR) trades at $0.35 with AI Score 44/100 (Grade C). Danimer Scientific, Inc. Market cap: $1.06M, Sector: Basic materials.

Price live · AI analysis from Jun 15, 2026
Danimer Scientific, Inc. develops and manufactures biodegradable bioplastics, primarily polyhydroxyalkanoates (PHA) under the Nodax brand, offering sustainable alternatives to traditional oil-derived plastics. The company targets brand owners and manufacturers in consumer packaging and plastics, aiming to capitalize on growing demand for eco-friendly materials despite operating with a negative profit margin and on the OTC market.

Analyst Coverage for DNMR: DNMR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DNMR against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 44/100 · C

DNMR: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Danimer Scientific, Inc. (DNMR) Materials & Commodity Exposure

CEORichard N. Altice
Employees257
HeadquartersBainbridge, US
IPO Year2020

Danimer Scientific, Inc. is an innovative polymer firm specializing in the creation and supply of eco-friendly bioplastics, including the Nodax PHA brand, as a sustainable alternative to conventional oil-derived plastics. The company targets consumer packaging and plastics manufacturers, positioning itself within the growing market for biodegradable materials.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for DNMR?

Danimer Scientific, Inc. presents an investment thesis centered on its position within the burgeoning bioplastics market, driven by increasing global demand for sustainable alternatives to traditional plastics. The company's proprietary polyhydroxyalkanoate (PHA) technology, marketed as Nodax, offers a fully biodegradable solution applicable across diverse product categories like films and food packaging. A key growth catalyst is the escalating consumer and regulatory pressure for eco-friendly packaging, which could significantly expand the addressable market for Danimer's products. The company's ability to scale production to meet this demand, as highlighted by its ongoing efforts, will be critical. However, the investment carries substantial risk, evidenced by its negative profit margin of -333.0% and gross margin of -57.7%, indicating significant operational challenges and a need for improved cost efficiencies. Its small market capitalization of $1.06M and OTC Other listing further underscore financial risk, including potential difficulties in securing additional funding. Investors must closely monitor the company's progress towards profitability and its capacity to convert market demand into scalable, financially viable operations.

Based on FMP financials and quantitative analysis

DNMR Key Highlights

  • Market Capitalization: $0.00B (or $1.06M from AI insight), reflecting a micro-cap valuation and inherent volatility.
  • Profit Margin: -333.0%, indicating substantial losses relative to revenue and significant operational inefficiencies.
  • Gross Margin: -57.7%, suggesting that the cost of goods sold far exceeds revenue, highlighting challenges in production economics.
  • Beta: 1.63, indicating higher volatility compared to the broader market, suggesting increased risk for investors.
  • Employees: 257 employees, a relatively lean workforce for a specialty chemicals firm focused on R&D and manufacturing.

Who Are DNMR's Competitors?

DNMR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HGRAF HydroGraph Clean Power Inc. $3.43 -3.11% $1.20B 69
LWLG Lightwave Logic, Inc. $7.46 +1.29% $1.15B 69
COOSF Carbios SAS $6.50 -9.09% $109.66M 69
NVZMY Novozymes A/S $63.45 -2.53% $29.58B 62
ELKEF Elkem ASA $3.40 +0.00% $2.16B 50
GVDBF Givaudan S.A. $3440.15 -18.91% $31.75B 50
AVNT Avient Corporation $38.83 +4.07% $3.56B 50
HWKN Hawkins, Inc. $139.44 +0.69% $2.92B 50

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are DNMR's Key Strengths?

  • Proprietary and versatile Nodax PHA biopolymer technology.
  • Focus on a growing market for sustainable and biodegradable plastics.
  • Diverse product forms catering to various manufacturing processes.
  • Established in 2004, indicating over two decades of experience in the field.

What Are DNMR's Weaknesses?

  • Significant financial losses with a -333.0% profit margin and -57.7% gross margin.
  • Small market capitalization of $1.06M, indicating limited financial resources.
  • Operates on the OTC Other market, limiting investor access and liquidity.
  • Challenges in scaling production and securing further funding.

What Could Drive DNMR Stock Higher?

  • Successful securing of further funding to support operations and scale production.
  • Progress towards achieving profitability and improving gross margins from current negative levels.
  • Expansion of production capacity to meet anticipated growing market demand for bioplastics.
  • Development and commercialization of new biopolymer formulations for diverse applications.
  • Formation of strategic partnerships with major brand owners or plastic converters to integrate Nodax PHA into their supply chains.

What Are the Key Risks for DNMR?

  • Financial-distress signal — its Altman Z-Score of -1.41 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-47.4%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
  • Significant financial losses, as evidenced by a -333.0% profit margin and -57.7% gross margin, posing a threat to long-term viability.
  • Inability to secure sufficient additional funding to scale operations and cover ongoing expenses, given its small market capitalization and OTC listing.
  • Intense competition from both traditional plastic manufacturers and other bioplastics producers, potentially limiting market share and pricing power.
  • Challenges in scaling production efficiently and cost-effectively to meet market demand while improving profitability.
  • Regulatory shifts or changes in consumer preferences that could impact the demand for specific bioplastic solutions or favor alternative sustainable materials.

What Are the Growth Opportunities for DNMR?

  • Expanding into Sustainable Packaging Markets: The global push for sustainable packaging solutions presents a significant growth avenue for Danimer Scientific. With increasing consumer awareness and regulatory pressures, brands are actively seeking alternatives to single-use plastics. Danimer's Nodax PHA, being fully biodegradable, is well-suited for applications such as flexible films, food containers, and beverage straws. The sustainable packaging market is projected to reach over $400 billion by 2030, offering a substantial addressable market for Danimer to capture by partnering with major consumer goods companies and packaging converters.
  • Technological Advancements and Product Diversification: Continuous innovation in biopolymer science can unlock new applications and improve cost-effectiveness. Danimer's ongoing research and development efforts, particularly in enhancing the performance characteristics of PHA and PLA-based resins, can lead to new product formulations. Developing bioplastics with improved barrier properties, heat resistance, or processability could open doors to high-value segments currently dominated by conventional plastics, expanding its market reach beyond current applications in films and coatings.
  • Strategic Partnerships and Licensing Agreements: Collaborating with large chemical manufacturers or consumer brands can accelerate market penetration and scale production. Forming strategic alliances could provide Danimer Scientific with access to greater manufacturing capacity, broader distribution networks, and shared R&D resources. Licensing its proprietary Nodax technology to other producers could also generate revenue streams and increase the overall adoption of PHA, establishing its brand as a leader in biodegradable materials.
  • Geographic Expansion: While headquartered in the US, the demand for bioplastics is a global phenomenon. Expanding sales and distribution networks into key international markets, particularly in regions with stringent plastic regulations or high environmental consciousness like Europe and parts of Asia, represents a substantial growth opportunity. Establishing local manufacturing or distribution hubs could reduce logistics costs and improve responsiveness to regional market demands, tapping into diverse regulatory landscapes and consumer preferences.
  • Addressing Niche High-Value Applications: Beyond mass-market packaging, Danimer Scientific can target niche, high-value applications where biodegradability is paramount and customers are willing to pay a premium. This could include specialized agricultural films, medical device components, or certain industrial applications where plastic waste accumulation is a critical concern. Focusing on these segments could provide higher margins and demonstrate the superior environmental benefits of its biopolymers, building a strong reputation for performance in demanding environments.

What Opportunities Does DNMR Have?

  • Increasing global consumer demand and regulatory pressure for sustainable packaging.
  • Potential for new applications and product diversification through R&D.
  • Strategic partnerships to expand manufacturing capacity and market reach.
  • Geographic expansion into international markets with high demand for bioplastics.

What Threats Does DNMR Face?

  • Intense competition from traditional plastics and other bioplastic producers.
  • High capital requirements for scaling production and ongoing R&D.
  • Economic downturns impacting consumer spending on premium sustainable products.
  • Regulatory changes that could favor alternative sustainable materials or impact production costs.

What Are DNMR's Competitive Advantages?

  • Proprietary Nodax PHA technology, offering a fully biodegradable and versatile plastic raw material.
  • Specialized expertise in biopolymer science and manufacturing processes.
  • Early mover advantage in developing and commercializing PHA-based solutions for various applications.
  • Focus on specific formulations like PLA-based resins for paper cup coatings, addressing niche market needs.

What Does DNMR Do?

Danimer Scientific, Inc., established in 2004 and headquartered in Bainbridge, Georgia, operates as an innovative polymer firm dedicated to the creation, manufacturing, and supply of eco-friendly bioplastics. Its core mission revolves around providing sustainable alternatives to conventional oil-derived plastics, addressing the increasing global demand for environmentally responsible materials. A cornerstone of its product portfolio is polyhydroxyalkanoate (PHA), a fully biodegradable plastic raw material marketed under the Nodax brand. This versatile biopolymer is engineered for a wide array of applications, including flexible films, drinking straws, various food packaging solutions, and other plastic products, demonstrating its adaptability across different manufacturing processes. Beyond PHA, Danimer Scientific also develops polylactic acid (PLA) based resins, specifically formulated for coating single-use paper cups, further expanding its reach into the sustainable packaging sector. The company's comprehensive suite of biopolymer solutions is available in multiple forms, such as additives, water-based coatings, fibers, filaments, films, and materials suitable for both thermoforming and injection molding processes. This broad product offering allows Danimer Scientific to cater to diverse industrial needs, enabling its clients to transition towards more sustainable product lines. Danimer Scientific strategically focuses its sales and marketing efforts on brand owners within the consumer packaging industry, plastic converters, and various manufacturers across the broader plastics sector. By targeting these key segments, the company aims to embed its biodegradable solutions into mainstream product development and supply chains. Its operations are centered on innovation in material science, striving to develop high-performance bioplastics that meet stringent industry standards while offering complete biodegradability, thereby mitigating the environmental impact associated with traditional plastics. The company's commitment to research and development underscores its ambition to remain at the forefront of the bioplastics revolution, continuously expanding its portfolio of sustainable polymer solutions.

What Products and Services Does DNMR Offer?

  • Develops and manufactures eco-friendly bioplastics as alternatives to traditional oil-derived plastics.
  • Produces polyhydroxyalkanoate (PHA) under the Nodax brand, a fully biodegradable plastic raw material.
  • Offers Nodax PHA for applications including films, drinking straws, and food packaging.
  • Develops polylactic acid (PLA) based resins for coating single-use paper cups.
  • Provides biopolymer products in various forms: additives, water-based coatings, fibers, filaments, and films.
  • Supplies materials suitable for thermoforming and injection molding processes.
  • Targets brand owners in consumer packaging, plastic converters, and manufacturers in the plastics sector.
  • Operates from its headquarters in Bainbridge, Georgia.

How Does DNMR Make Money?

  • Generates revenue through the sale of proprietary bioplastic raw materials like Nodax PHA and PLA-based resins.
  • Sells directly to brand owners, plastic converters, and manufacturers for integration into their product lines.
  • Focuses on B2B sales within the consumer packaging and broader plastics sectors.
  • Emphasizes the environmental benefits and performance characteristics of its biodegradable polymers as a value proposition.

What Industry Does DNMR Operate In?

Danimer Scientific operates within the Chemicals - Specialty industry, a segment of the broader Basic Materials sector, specifically focusing on the rapidly evolving bioplastics market. This industry is characterized by increasing innovation aimed at developing sustainable alternatives to conventional fossil fuel-derived plastics, driven by environmental concerns, consumer preferences, and regulatory mandates. The global bioplastics market is projected for significant growth, with estimates often pointing to double-digit compound annual growth rates over the next decade. Danimer Scientific positions itself as a key player in the polyhydroxyalkanoate (PHA) segment, a highly promising class of fully biodegradable polymers. While the market offers substantial opportunity, it is also competitive, featuring both established chemical giants diversifying into bioplastics and emerging specialized firms. Danimer's challenge lies in scaling its proprietary technology and achieving cost-effectiveness to compete effectively against both traditional plastics and other bioplastic alternatives like PLA and starch-based polymers.

Who Are DNMR's Key Customers?

  • Brand owners in the consumer packaging industry seeking sustainable material solutions.
  • Plastic converters who process raw polymers into finished plastic products.
  • Manufacturers across the broader plastics sector looking for eco-friendly alternatives.
  • Companies requiring biodegradable materials for films, coatings, straws, and food packaging.
AI Confidence: 68% Updated: Jun 15, 2026

FY2026 estForward Outlook

Wall Street analysts project Danimer Scientific, Inc. revenue of about $185.1M for fiscal 2026, with EPS near $-13.46.

DNMR Valuation & Market Position

With a $1.06M market cap, Danimer Scientific, Inc. sits in the micro-cap segment of the market. Relative to its peer group, DNMR's quantitative score of 44/100 is below the peer average of 64/100.

ROE -47%Key Financial Metrics

Return on equity for Danimer Scientific, Inc. stands at -47.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -22.3%, showing how much profit it generates from its asset base. A current ratio of 6.87 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 1/9Financial Health

Danimer Scientific, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.41 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Danimer Scientific, Inc. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Bainbridge, US. The company is led by CEO Richard N. Altice. DNMR has traded publicly since 2020.

DNMR Financials

Fundamental Snapshot

Return on Equity (TTM)
-47.4%
Current Ratio
6.9

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Proprietary and versatile Nodax PHA biopolymer technology.
  • Focus on a growing market for sustainable and biodegradable plastics.
  • Diverse product forms catering to various manufacturing processes.
  • Established in 2004, indicating over two decades of experience in the field.

Bear Case

  • Significant financial losses with a -333.0% profit margin and -57.7% gross margin.
  • Small market capitalization of $1.06M, indicating limited financial resources.
  • Operates on the OTC Other market, limiting investor access and liquidity.
  • Challenges in scaling production and securing further funding.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

DNMR Latest News

DNMR Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DNMR.

Price Targets

Wall Street price target analysis for DNMR.

DNMR MoonshotScore

44/100

What does this score mean?

The MoonshotScore rates DNMR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Richard N. Altice

Chief Executive Officer

Richard N. Altice serves as the Chief Executive Officer of Danimer Scientific, Inc., overseeing a workforce of 257 employees. His leadership is crucial for guiding the company's strategic direction in the innovative bioplastics sector. While specific details about his prior career history, educational background, or previous roles are not provided in the source data, his position at the helm of a specialty chemicals firm suggests a background in manufacturing, materials science, or corporate management within industrial sectors. His role involves navigating the complexities of developing, producing, and commercializing biodegradable polymer solutions.

Track Record: Under Richard N. Altice's leadership, Danimer Scientific continues to focus on the development and production of biodegradable materials, primarily polyhydroxyalkanoates (PHAs). The company's core business revolves around offering alternatives to traditional plastics, a strategy that aligns with growing consumer demand for sustainable packaging solutions. Key strategic decisions under his tenure likely include efforts to scale production and secure further funding, critical steps for a company operating in an emerging technology market.

DNMR OTC Market Information

Danimer Scientific, Inc. trades on the OTC Other tier of the OTC Markets. This tier is for companies that do not meet the financial or disclosure standards of OTCQX or OTCQB, or that are not required to report to the SEC. Unlike major exchanges like NYSE or NASDAQ, which have stringent listing requirements regarding market capitalization, share price, and financial reporting, the OTC Other tier has minimal to no public disclosure requirements. This often means less transparency for investors compared to exchange-listed or even higher-tier OTC stocks, making due diligence more challenging.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: With a small market capitalization of $1.06M and an OTC Other listing, Danimer Scientific's stock likely experiences very low trading volume and potentially wide bid-ask spreads. This illiquidity means it can be difficult for investors to buy or sell shares quickly without significantly impacting the stock price. The limited number of buyers and sellers can lead to substantial price volatility and challenges in executing trades at desired prices.
OTC Risk Factors:
  • Limited Transparency: Unknown disclosure status means limited access to financial statements and operational updates, making informed decision-making difficult.
  • Low Liquidity: Small market cap and OTC Other listing typically result in low trading volume, making it hard to buy or sell shares without price impact.
  • Price Volatility: Illiquidity and limited information can lead to extreme price swings, increasing investment risk.
  • Difficulty in Capital Raising: The OTC Other status can deter institutional investors, making it harder for the company to secure necessary funding for growth and operations.
  • Lack of Analyst Coverage: Typically, OTC Other stocks receive no analyst coverage, leaving investors without independent research and valuation insights.
Due Diligence Checklist:
  • Verify the most recent financial statements and auditor reports, if any are available.
  • Research management's background, track record, and current compensation.
  • Examine any available news, press releases, or corporate filings for operational updates.
  • Assess the competitive landscape and market demand for the company's products independently.
  • Understand the company's capital structure, debt levels, and financing needs.
  • Evaluate the company's ability to scale production and achieve profitability.
  • Consider the long-term viability of the bioplastics market and Danimer's position within it.
Legitimacy Signals:
  • Established in 2004, indicating a long operational history, albeit with recent financial challenges.
  • Focus on a tangible product (bioplastics) with a clear market need (sustainable alternatives).
  • Identified CEO (Richard N. Altice) and a stated number of employees (257).
  • Headquartered in Bainbridge, US, suggesting a physical operational presence.
  • Proprietary product brand (Nodax PHA) implies investment in R&D and intellectual property.

Danimer Scientific, Inc. Basic Materials Stock: Key Questions Answered

What does Danimer Scientific, Inc. do?

Danimer Scientific, Inc. is a specialty chemicals company focused on developing, manufacturing, and supplying eco-friendly bioplastics designed to replace conventional oil-derived plastics. Its primary product is polyhydroxyalkanoate (PHA), sold under the Nodax brand, which is a fully biodegradable plastic raw material. Nodax PHA is utilized in various applications such as films, drinking straws, and food packaging. The company also produces polylactic acid (PLA) based resins for coating single-use paper cups. Danimer Scientific offers its biopolymer products in multiple forms, including additives, coatings, fibers, filaments, and materials for thermoforming and injection molding, targeting brand owners, plastic converters, and manufacturers in the broader plastics sector from its Bainbridge, Georgia headquarters.

What are the key financial metrics investors watch for DNMR?

For Danimer Scientific, Inc., investors should closely monitor several key financial metrics given its current operational stage and market position. The profit margin of -333.0% and gross margin of -57.7% are critical indicators of the company's profitability challenges; improvement in these figures would signal progress towards financial health. Its market capitalization of $1.06M highlights its micro-cap status and associated risks. Investors should also track revenue growth to assess market penetration and demand for its bioplastics, although specific revenue figures are not provided. Furthermore, the Beta of 1.63 suggests higher volatility compared to the market, which is important for risk assessment. Given its OTC Other listing, monitoring cash flow and funding rounds will be crucial for evaluating its ability to sustain operations and scale production.

What are the main risks for DNMR?

Danimer Scientific, Inc. faces several significant risks that investors may want to evaluate. Operationally, the company exhibits substantial financial losses, as indicated by a profit margin of -333.0% and a gross margin of -57.7%, raising concerns about its long-term financial viability and ability to achieve profitability. There is a potential risk related to securing sufficient additional funding, which is critical for scaling production and covering ongoing expenses, especially given its small market capitalization and OTC Other listing, which can deter institutional investors. The bioplastics market is highly competitive, with threats from both established traditional plastic manufacturers and other bioplastic producers, potentially impacting market share and pricing power. Furthermore, the company faces challenges in efficiently scaling its production processes to meet growing demand while simultaneously improving its cost structure.

What are the key factors to evaluate for DNMR?

Danimer Scientific, Inc. (DNMR) holds an AI score of 44/100 (low). Not financial advice.

How frequently does DNMR data refresh on this page?

DNMR prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven DNMR's recent stock price performance?

Danimer Scientific, Inc. (DNMR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary and versatile Nodax PHA biopolymer technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider DNMR overvalued or undervalued right now?

Valuing Danimer Scientific, Inc. (DNMR) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying DNMR?

Before investing in Danimer Scientific, Inc. (DNMR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Growth opportunities and SWOT analysis involve some inference based on the company's stated business and industry trends, as specific details were not always provided in the source data.
  • Competitors section is empty as no FMP PEER TICKERS were provided in the source data as explicitly required.
  • CEO background and track record are limited to information inferable from the provided data, as specific details were not given.
  • OTC disclosure status is 'Unknown' as per source data, which impacts the depth of analysis for financial reporting.
Data Sources

Popular Stocks